PPT-INTRODUCTION TO DRUG REGULATORY SYSTEM.

Author : levi903 | Published Date : 2024-09-09

Drug Regulation means the control of Drug by regulatory authority to ensure safety efficacy quality of drug This is achieved by following and practicing the good

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "INTRODUCTION TO DRUG REGULATORY SYSTEM." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

INTRODUCTION TO DRUG REGULATORY SYSTEM.: Transcript

Drug Regulation means the control of Drug by regulatory authority to ensure safety efficacy quality of drug This is achieved by following and practicing the good practices in pharmaceutical 1 Science Integration . 3 March 2011 . Mike Murphy DVM, JD, PhD. Veterinary Medical Officer. Division of Surveillance. Advertising Issues, . Effectiveness Claims. 2. AAVPT Veterinary Drug Regulatory Cycle (A to Z). 3 March 2011 . the Pharmaceutical Sector - Current Scenario and Main . Challenges. . Dr. B R JAGASHETTY. . B.Sc. ; . M.Pharm. ; LLB; . Ph.D. Drugs Controller, Karnataka State. 04.10.2013 . Mark . Atalla. , . PharmD. Disclosure. I have no relevant financial relationships with commercial interests pertaining to the content presented in this program. Objectives. 3. Key Things to Walk Away With:. 3 March 2011 . Mike Murphy DVM, JD, PhD. Veterinary Medical Officer. Division of Surveillance. Advertising Issues, . Effectiveness Claims. 2. AAVPT Veterinary Drug Regulatory Cycle (A to Z). 3 March 2011 . Marlene E. Haffner, MD, MPH. CEO, Haffner Associates, LLC. Orphan Drugs Summit 2012. Thursday, 27. th. September 2012. Current . Pharma. Trends. Slow . pharma. industry growth. Patent expiration. HIV Cure Research Training Curriculum. Regulatory Issues Module by:. Damon Deming, Ph.D.. FDA Division of Antiviral Products. Nov 2014 . The HIV CURE training curriculum is a collaborative project aimed at making HIV cure research science accessible to the community and the HIV research field. . Carolyn Compton, M.D., Ph.D.,. CEO and . President. Critical Path Institute . (. C-Path). IOM Workshop International Regulatory Harmonization. Washington, DC. February 13, 2013. The Global Challenge. Access and Rational Use. Blood, Radiological and Pharmaceutical Services. Regulatory System Strengthening. Systems approach/ Across all technologies. Contemplate the specificities off specific technologies. WHO Technical Briefing Seminar on Essential Medicines and Health Products. 31 October 2013. WHO Headquarters, Geneva, Salle M 505. Dr Claudia P Alfonso . Outline. Global overview of vaccine production and immunization . Investigational New Drug Application (IND); Summary of regulations and guidelines . Introduction of . cGMP's. /principles of validation . Introduction to QA/QC principles . Good Laboratory Practice (GLP) compliance . WHO Technical Briefing Seminar on Essential Medicines and Health Products. 31 October 2013. WHO Headquarters, Geneva, Salle M 505. Dr Claudia P Alfonso . Outline. Global overview of vaccine production and immunization . Carolyn Compton, M.D., Ph.D.,. CEO and . President. Critical Path Institute . (. C-Path). IOM Workshop International Regulatory Harmonization. Washington, DC. February 13, 2013. The Global Challenge. patent brand-name medicines. Low-cost generic drugs—Food and Drug Administration (FDA)-approved, interchangeable versions of the same products made by different manufacturers—were considered Regulatory . Bodies. Drug . Regulatory . Authority. The drug . regulatory . authority . (DRA) . is the agency that develops . and . implements . most . of . the . legislation . and . regulations on.

Download Document

Here is the link to download the presentation.
"INTRODUCTION TO DRUG REGULATORY SYSTEM."The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.